The user facility reported to terumo cardiovascular that the partial pressure of carbon dioxide (pco2) was too high.It is unknown when this event occurred, whether the product was changed out, or if there was any effect on the patient or results of the surgery.Due to the unknown information for this event, it is being reported.Terumo continues to attempt to gain more information regarding this event from the user facility.
|
This follow-up report is submitted to fda in accord with applicable regulations ¿ and as indicated by terumo cardiovascular systems in the initial report submitted to the fda on may 31, 2019. upon further investigation of the reported event, the following information is new and/or changed: d4 (additional device information - added exp date).G4 (date received by manufacturer).G7 (indication that this is a follow-up report).H2 (follow-up due to additional information).H4 (device manufacture date).H6 (identification of evaluation codes 11, 3331, 4114, 3221, 67, 4315).Method code #1: 11 - testing of device from same lot/batch retained by manufacturer.Method code #2: 3331 - analysis of production records.Method code #3: 4114 - device not returned.Results code: 3221 - no findings available.Conclusions code: 67 - no problem detected.Conclusions code: 4315 - cause not established.The actual sample was not returned for evaluation.A retention sample from the same product code and lot number was obtained and visually inspected with no visual anomalies noted.It was gas calibrated and successfully pass.The retention sample was then circulated with buffer solution; it was found to produce acceptable values on the cdi500 monitor and both samples performed as expected.Without a returned device, a complete investigation could not be performed and a definitive root cause could not be determined.All available information has been placed on file in quality management for appropriate tracking, trending, and follow-up.
|